Regulatory data is for reference only. Always verify with the official regulator before making formulation decisions. Last refreshed: 10/11/2026.
Ingredients/4,4'-(1,3-Phenylene-bis(1-methylethylidene))bis-phenol
4,4'-(1,3-Phenylene-bis(1-methylethylidene))bis-phenolCAS 13595-25-0
EU CosIng II — prohibitedASEAN II — prohibitedUK OPSS — prohibited
Is 4,4'-(1,3-Phenylene-bis(1-methylethylidene))bis-phenol restricted in cosmetics?
4,4'-(1,3-Phenylene-bis(1-methylethylidene))bis-phenol is prohibited in EU CosIng, ASEAN and UK OPSS. Markets not named here hold no entry for it, which is not a clearance.
- CAS
- 13595-25-0
- INCI
- 4,4'-(1,3-Phenylene-bis(1-methylethylidene))bis-phenol
- Data refreshed
- 2026-10-11
Regulatory status
What this means
4,4'-(1,3-Phenylene-bis(1-methylethylidene))bis-phenol has regulatory signals in EU CosIng, ASEAN, UK OPSS. Review the source links above for the official conditions and latest updates.
Recent regulatory changes
No recorded regulatory changes for 4,4'-(1,3-Phenylene-bis(1-methylethylidene))bis-phenol yet.
Common questions
- Is 4,4'-(1,3-Phenylene-bis(1-methylethylidene))bis-phenol restricted in EU cosmetics?
- 4,4'-(1,3-Phenylene-bis(1-methylethylidene))bis-phenol is prohibited in EU cosmetics according to EU CosIng Annex II.
- Is 4,4'-(1,3-Phenylene-bis(1-methylethylidene))bis-phenol restricted under the ASEAN Cosmetic Directive?
- 4,4'-(1,3-Phenylene-bis(1-methylethylidene))bis-phenol is prohibited under the ASEAN Cosmetic Directive Annex II.
- Is 4,4'-(1,3-Phenylene-bis(1-methylethylidene))bis-phenol restricted in UK OPSS?
- 4,4'-(1,3-Phenylene-bis(1-methylethylidene))bis-phenol is prohibited in cosmetics under UK OPSS.
- What is the CAS number for 4,4'-(1,3-Phenylene-bis(1-methylethylidene))bis-phenol?
- The CAS number for 4,4'-(1,3-Phenylene-bis(1-methylethylidene))bis-phenol is 13595-25-0.
Check this ingredient in a formula across 11 markets
This page covers one ingredient on its own. Sign up free to check it at your actual concentration, in a full formula, with GHS hazards and per-market verdicts.